Clinical Trial Update: Talazoparib in Advanced Breast Cancer Patients With Homologous Recombinant Deficiency [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating talazoparib in advanced breast cancer patients with homologous recombination deficiency; the study is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Talazoparib (talazoparib)

Snippet

Sponsor: Seoul National University Hospital | Conditions: Advanced Breast Cancer | Phase 2 | Status: RECRUITING